Phillip B. Storm - Faculty Biosketch

Phillip B. Storm, M.D.

Professor of Neurosurgery at the Children's Hospital of Philadelphia

Attending Neurosurgeon, Children’s Hospital of Philadelphia

Chief of Neurosurgery, Children's Hospital of Philadelphia

Leslie Sutton Endowed Chair Holder, Children's Hospital of Philadelphia

Director of the Center for Data Driven Discovery in Biomedicine (D3b), Children's Hospital of Philadelphia

Co-Director Neuroscience Center, Children's Hospital of Philadelphia

Vice Chair of Clinical Affairs, Department of Surgery, Children's Hospital of Philadelphia

Department: Neurosurgery

Contact information

The Children's Hospital of Philadelphia
34th St & Civic Center Boulevard
Philadelphia, PA 19104

Office: (215) 590-2780
Fax: (215) 590-4809

Email:
storm@chop.edu

Links
Rare enough podcast
Launch of the Center of Data Driven Discovery in Biomedicine
Strive Podcast
ARPA-H RADIANT video
Creation of the largest pediatric brain tumor atlas
Chai Lifeline community service
Philadelphia Coalition for a Cure (PC4C) is first of its kind precision medicine study supporting collaborative discovery for brain tumors with NantHealth's GPS Cancer Test across pediatric and adult patients
Launch of Cavatica, a new cloud-based environment for securely storing, sharing and analyzing large volumes of pediatric cancer patient genomics data

Education:
B.A. (Chemistry & Sociology)
Wake Forest University, 1990.
M.D.
Johns Hopkins University School of Medicine (AOA), 1996.

Post-Graduate Training
Intern, General Surgery, Johns Hopkins Hospital, 1996-1997.
Resident, Neurosurgery, Johns Hopkins Hospital, 1997-2000.
Neuro-Oncology Research Fellow, Johns Hopkins Hospital, 2000-2002.
Pediatric Neurosurgery Fellow, The Children’s Hospital of Philadelphia, 2003-2004.

Certifications
American Board of Neurological Surgery, Primary Exam, 2000.
Gamma Knife Radiosurgery Training Program, University of Pittsburgh, 2002.
American Board of Neurological Surgery, Oral Exam, 2010.
Pediatric Neurosurgery Board Certification, 2013.

Permanent link

> Perelman School of Medicine > Faculty > Details

Selected Publications

Chrysochoou D, Gandhi DB, Adib S, Familiar AM, Vunnava B, Varshochi S, Khalili N, Khalili N, Ware JB, Tu W, Jain P, Anderson H, Haldar S, Storm PB, Franson A, Prados M, Kline C, Mueller S, Resnick A, Vossough A, Davatzikos C, Nabavizadeh A, Kazerooni AF.: AI-powered segmentation and prognosis with missing MRI in pediatric brain tumors. NPJ Precis Oncol Jan 2026.

Corbett RJ, Kaufman RS, McQuaid SW, Vaksman Z, Phul S, Brown MA, Mason JL, Waszak SM, Zhang B, Zhong C, Blauel E, Desai H, Hausler R, Naqvi AS, Daggett JM, Sickler A, Cresswell-Clay EC, Sullivan PJ, Chroni A, Geng Z, Gonzalez EM, Zhu Y, Heath AP, Li M, Storm PB, Resnick AC, Maxwell KN, Cole KA, Waanders AJ, Bornhorst M, MacFarland SP, Rokita JL, Diskin SJ.: Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric central nervous system tumors. Nat Commun Nov 2025.

Kann BH, Vossough A, Brüningk SC, Familiar AM, Aboian M, Linguraru MG, Yeom KW, Chang SM, Hargrave D, Mirsky D, Storm PB, Huang RY, Resnick AC, Weller M, Mueller S, Prados M, Peet AC, Villanueva-Meyer JE, Bakas S, Fangusaro J, Nabavizadeh A, Kazerooni AF; Response Assessment in Pediatric Neuro-Oncology (RAPNO) group.: Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 1: review of the current state of the art. Lancet Oncol Nov 2025.

Kazerooni AF, Familiar AM, Aboian M, Brüningk SC, Vossough A, Linguraru MG, Huang RY, Hargrave D, Peet AC, Resnick AC, Storm PB, Mirsky D, Yeom KW, Weller M, Prados M, Chang SM, Mueller S, Villanueva-Meyer JE, Bakas S, Fangusaro J, Kann BH, Nabavizadeh A; Response Assessment in Pediatric Neuro-Oncology (RAPNO) group.: Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 2: challenges, opportunities, and recommendations for clinical translation. Lancet Oncol Nov 2025.

Madsen PJ, Schlitter AM, Flemmig C, Dickson C, Harvey K, Wilson C, Beaubien E, Patterson L, Stern A, Griffin C, Joshi N, Hajeebu S, Martinez D, Storm PB, Resnick AC, Hillemanns P, Stanulla M, Faber J, Wingerter A, Gaida MM, Holtemeyer S, Laible M, Feldner A, Frohns F, Duarte JH, Sinn BV, Wöll S, Sahin U, Türeci Ö, Foster JB.: Claudin 6 is a suitable target for CAR T-cell therapy in atypical teratoid/rhabdoid brain tumors and other pediatric solid tumors. J Immunother Cancer 13: e011709, Oct 2025.

Stern A, Jain A, Stein A, Storm PB, Rosenblum J, Pisapia JM.: Targeted tumor resection to reestablish cerebrospinal fluid flow in the setting of a pediatric third ventricular glioma with obstructive hydrocephalus. Surg Neurol Int 16: 359, Aug 2025.

Foster JB, Madsen PJ, Harvey K, Griffin C, Stern A, Patterson L, Joshi N, Dickson C, McManus O, Beaubien E, Wilson C, Beale DR, Baubet V, Goel P PN, Vitanza NA, Nazarian J, Koptyra M, Storm PB, Resnick AC.: Transient mRNA CAR T cells targeting GD2 provide dose-adjusted efficacy against diffuse midline glioma and high grade glioma models. Neuro Oncol May 2025.

Kraya A, Rathi K, Jin R, Kesherwani V, Resnick AC, Storm PB, Nabavizadeh A.: Evaluating the Potential of PSMA Targeting in CNS Tumors: Insights from Large-Scale Transcriptome Profiling. Cancers (Basel) 17: 1239, Apr 2025.

Castellanos M, Lerner DK, Hamimi SA, Workman AD, Douglas JE, Kohanski MA, Storm PB, Palmer JN, Adappa ND.: Safety and feasibility of the endoscopic endonasal approach to anterior skull base tumour resections in young children. Rhinology 63: 383-384, Mar 2025.

Corbett RJ, Kaufman RS, McQuaid SW, Vaksman Z, Phul S, Brown MA, Mason JL, Waszak SM, Zhang B, Zhong C, Desai H, Hausler R, Naqvi AS, Chroni A, Geng Z, Gonzalez EM, Zhu Y, Heath AP, Li M; Penn Medicine BioBank; Regeneron Genetics Center; Storm PB, Resnick AC, Maxwell KN, Cole KA, Waanders AJ, Bornhorst M, MacFarland SP, Rokita JL, Diskin SJ.: Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric CNS tumors. medRxiv Feb 2025.